Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

AGM Statement

17 Jun 2021 07:00

RNS Number : 1544C
Anpario PLC
17 June 2021
 

17 June 2021

 

Anpario plc("Anpario" or the "Company")

 

AGM Statement

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today. Peter Lawrence, Chairman, will make the following comments:

 

"The Board would firstly like to thank all our staff and other stakeholders for their continued efforts in ensuring production and delivery of our products to our customers and subsidiaries around the world especially during this challenging period caused by the Covid 19 pandemic.

 

The Company has delivered good sales and improved profit performance with sales at a similar level to last year, which was a very strong comparative period as customers had increased stock levels at the onset of the pandemic. Most regions are performing to plan with China experiencing a very strong performance, benefiting from last year's ban on anti-biotic growth promoters (AGPs) in animal feed. South East Asia's performance is, however, weaker as countries imposed new lockdowns in response to increasing infection rates and, with less tourism which has reduced overall protein consumption.

 

Our Brexit contingency plans are working well, helping to reduce disruption and we now look forward to our efforts coming to fruition now supported by our European stockholding hub.

 

As with most industries, we are experiencing raw material price inflation and some disruption in our supply chains and global shipping operations. However, we are implementing price increases to help mitigate the increase in costs and our export and logistics team is managing to overcome the logistics issues. We expect these challenges to continue until the last quarter of this year.

 

It is worth noting that Anpario's unique formulation technology also benefits customers as we are able to offer solutions which are more cost effective than alternative competitor products.

 

We are encouraged by some recent business development successes including a large Brazilian poultry integrator using Orego-Stim® and growth in Latin America for our aquaculture products, which are currently being launched in specific countries across Asia. Our exciting growth opportunities and strong balance sheet, which is reflected in our strong cash position, gives me confidence that the Company will continue to develop and grow in the years ahead.

 

Finally, this is my last AGM as I retire from the Board today. I would therefore like to take the opportunity to thank all staff and shareholders for their loyalty and support of Anpario in helping to build a successful company which has delivered significant shareholder value. As I hand over the Chair to Kate Allum, I am confident that the board with its newer members, will successfully continue to steer the company through these unusual times to ensure to deliver value to our shareholders.

 

The Company's interims for the six months period ended 30 June 2021 are expected to be announced on 15 September 2021."

 

 

Enquiries:

Anpario plc

Richard Edwards, Chief Executive Officer

+44 (0)7776 417 129

Karen Prior, Group Finance Director

+44 (0)1909 537 380

Peel Hunt LLP (NOMAD and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Will Bell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSERTIRLIL
Date   Source Headline
22nd Jun 202211:24 amRNSAGM Statement
16th Jun 20226:00 pmRNSResult of AGM
16th Jun 20227:00 amRNSAGM Statement
27th May 202212:56 pmRNSHolding(s) in Company
24th May 20221:10 pmRNSHolding(s) in Company
11th May 20227:00 amRNSNotice of AGM
10th May 20223:55 pmRNSHolding(s) in Company
5th May 20223:18 pmRNSHolding(s) in Company
4th May 20221:14 pmRNSTotal Voting Rights
28th Apr 202211:17 amRNSHolding(s) in Company
20th Apr 20221:49 pmRNSHolding(s) in Company
19th Apr 20223:47 pmRNSHolding(s) in Company
8th Apr 20227:00 amRNSDirectorate Change
6th Apr 202210:10 amRNSHolding(s) in Company
6th Apr 202210:09 amRNSTotal Voting Rights
1st Apr 20223:41 pmRNSHolding(s) in Company
25th Mar 202210:40 amRNSHolding(s) in Company
24th Mar 202212:57 pmRNSGrant of share awards
22nd Mar 20225:08 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results
8th Mar 20222:35 pmRNSBlock listing Interim Review
8th Mar 20222:34 pmRNSTotal Voting Rights
26th Jan 20227:00 amRNSFull Year Trading Statement
3rd Dec 20217:00 amRNSUK patent granted for Orego-stim
18th Nov 20211:17 pmRNSHolding(s) in Company
10th Nov 20217:00 amRNSNew Commitment to Sustainable Operations
3rd Nov 202112:04 pmRNSTotal Voting Rights
1st Nov 202110:03 amRNSHolding(s) in Company
26th Oct 20214:28 pmRNSHolding(s) in Company
12th Oct 20217:20 amRNSDirector/PDMR Shareholding
15th Sep 202111:51 amRNSHalf-year Report - Replacement
15th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20219:52 amRNSTotal Voting Rights
20th Jul 20219:42 amRNSBlock listing Interim Review
9th Jul 20212:16 pmRNSAnpario receives “Community Business Hero Award"
17th Jun 20211:24 pmRNSResult of AGM
17th Jun 20217:00 amRNSAGM Statement
7th Jun 20213:58 pmRNSDirector/PDMR Shareholding
24th May 20219:48 amRNSHolding(s) in Company
18th May 20217:00 amRNSNotice of AGM
4th May 20214:16 pmRNSDirector/PDMR Shareholding
4th May 20214:10 pmRNSTotal Voting Rights
28th Apr 20214:00 pmRNSDirector/PDMR Shareholding
22nd Apr 20214:05 pmRNSDirector/PDMR Shareholding
19th Apr 20217:00 amRNSBoard update
13th Apr 20219:17 amRNSHolding(s) in Company
13th Apr 20219:17 amRNSHolding(s) in Company
6th Apr 20211:50 pmRNSDirector/PDMR Shareholding
30th Mar 20213:39 pmRNSDirector/PDMR Shareholding
17th Mar 20217:01 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.